Haloderm S Ointment is a topical formulation containing Halobetasol propionate 0.05% w/w, a potent corticosteroid, combined with Salicylic Acid 3% w/w, a keratolytic agent. This combination is indicated for the treatment of various inflammatory and hyperkeratotic dermatoses such as psoriasis, eczema, and lichen planus. Halobetasol exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the skin. Salicylic Acid facilitates the removal of scales and promotes the penetration of Halobetasol by softening and exfoliating the stratum corneum. Haloderm S Ointment is applied topically in a thin layer to the affected areas once or twice daily, as directed by a healthcare professional. It is essential to avoid prolonged use or application on large surface areas to minimize the risk of systemic absorption and corticosteroid-related adverse effects such as skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression. The ointment should not be used on infected or broken skin and is contraindicated in patients with hypersensitivity to any of its components. Consultation with a dermatologist is recommended before initiating therapy to ensure appropriate use and monitoring.